Numerous viral and bacterial pathogens have been reported causing acute respiratory tract infection (ARTI). Nasopharyngeal swab (NPS) specimens from 351 patients (278 children, 73 adults) with suspected upper and lower ARTI were submitted during the study period from Jan. 2005 to Dec. 2006. Organism-specific nucleic acids were detected using TemPlex technology (ResPlex I and II, Genaco Biomedical Products, Huntsville, AL). Amplified products were identified using a suspension array for multiplex detection performed on a Luminex 100 instrument (Luminex, Austin, TX 91 bacteria), followed by winter (24 infections), autumn (18 infections) and summer (12 infections). The prevalence of co-infection is ~40%, finding a much higher incidence of co-infection with more than one agent than that reported previously.
Introduction
Acute respiratory tract infections (ARTIs) are common among children and adults. Many bacterial and viral pathogens can cause ARTIs. Since bacterial and viral ARTIs usually present with similar signs and symptoms, it is difficult to distinguish them from each other by their clinical findings (1) . Mycoplasma pneumoniae, Legionella pneumophila, Chlamydophila pneumoniae, Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, and Acinetobacter baumannii as bacterial respiratory pathogens and influenza A virus (Flu-A) and Flu-B, respiratory syncytial virus (RSV) A and B, parainfluenza virus 1 (PIV-1), PIV-2, PIV-3, and PIV-4, human metapneumovirus (hMPV), rhinoviruses (RhVs), enteroviruses (EnVs), and severe acute respiratory syndrome (SARS) coronavirus (CoV) as viral respiratory pathogens are well recognized (2, 3) . Rapid and accurate diagnosis of these pathogens is very important for initiating antiviral and antibacterial therapy, preventing nosocomial spread, decreasing the duration of hospital stay, and 3 Disease and Molecular Medicine -www.dismolmed.org Turhan V et al.
Dis Mol Med 2013;1(1): [2] [3] [4] [5] [6] [7] reducing healthcare costs (3) . One of the important problems in the diagnosis of ARTIs is to make a distinction between causative infectious agents clinically. Conventional diagnosis of respiratory tract pathogens is usually based on the microbial culture, cell culture and/or detection of antigens. Culture techniques are very difficult for some pathogens, such as M. pneumoniae, L. pneumophila, C. pneumoniae, and viruses, and culturing pathogens is time-consuming (2,4). Molecular techniques have been established for detection of respiratory pathogens and they have some advantages over conventional methods. Therefore, multiplex RT-PCR-based techniques have been developed for simultaneous detection of a panel of respiratory pathogens in a single reaction (1) .
We reported here the use of ResPlex Kits (Genaco Biomedical Products, Huntsville, AL), which use a target-enriched multiplex PCR to amplify and detect a panel of gene targets within one reaction, to detect 20 bacterial and viral pathogens commonly encountered in the respiratory tract.
Materials and Methods

Clinical samples
Nasopharyngeal swab (NPS) specimens were collected over the study period from January 2005 to December 2006. The specimens were submitted to the Clinical Virology Laboratory at Vanderbilt University Medical Center for detection of respiratory viruses and bacterial pathogens. Specimens with sufficient residual volume after routine diagnostic testing were stored at -80oC for further study.
Total nucleic acid extraction
A NucliSens easyMAG platform (bioMerieux, Durham, NC) was used to extract total nucleic acid from the frozen NPS specimens. The starting specimen volume was 0.2 ml, and total nucleic acid was eluted in 55 μl of RNase-free water.
Genaco ResPlex I and II
The ResPlex I and II assays entail the simultaneous amplification of a total of 20 bacterial and viral pathogens. ResPlex Panel 1 covers DNA pathogens including M. pneumoniae, L. pneumophila, C. pneumoniae, N. meningitidis, S. pneumoniae, H. influenzae, and A. baumannii. ResPlex Panel 2 covers RNA pathogens including Flu-A, Flu-B, RSV-A, RSV-B, PIV-1, PIV-2, PIV-3, PIV-4, hMPV, RhVs, EnVs, and SARS CoV. Organism-specific nucleic acids were detected using TemPlex technology (6), followed by product detection and identification using a Luminex suspension microarray (3). In brief, 6µl ResPlex II and ResPlex I SuperPrimers were added to 25 µl of Qiagen HotStarTaq master Mix (Qiagen Inc, Valencia, CA), followed by the addition of 5 µl of extracted nucleic acid and 14 µl of water for a final volume of 50 µl. Amplification was initiated with reverse transcription at 50°C for 30 min, followed by the five-stage Templex cycling program, as previously described. Amplified products were identified using a suspension array for multiplex detection performed on a Luminex 100 instrument (Luminex, Austin, TX), as previously described. Results for each channel are expressed as the median fluorescence intensity (MFI) value. The cutoff value for each target was determined as the sum of the mean plus 4 times the standard deviations of the negative controls.
Patients Review
In total, 351 patients with suspected viral ARTI were retrospectively reviewed. A standardized set of 45 demographical, clinical and laboratory items was extracted from the patients' files, entered into Excel files, controlled, and reviewed by 2 infectious disease specialists blindly. All patients were categorized as upper, lower, and non-ARTI. Subjects were grouped as pediatric (age <18) and adult (age >18) patients. This study protocol was approved by the Vanderbilt University institutional local study review board and ethics committee.
Results
A total of 351 subsequently clinical samples collected from ARTI-suspected patients were tested. Of the patients included, 190 (54.1%) were male and 161 (45.9%) were female. There were 278 (79.2%) pediatric and 73 (20.8%) adult patients. The average age of the patients was 10 ± 18.24 years.
A total of 293 patients (248 children and 45 adults) was diagnosed as lower ARTI (39 children and 9 adults) and upper ARTI (209 children and 36 adults), whereas 58 patients (30 children and 28 adults) were not to fulfill ARTI entry criteria according to their clinical and laboratory findings (7) . In 150 of 293 (51.1%) ARTI patients, no infectious agent was detected in NPS samples. On the other hand, microorganisms (four bacteria and one virus) were detected in 5 of 58 (8.6%) non-ARTI patients Disease and Molecular Medicine -www.dismolmed.org Microorganisms in respiratory tract infections 
Discussion
Acute respiratory tract infections are the most common causes of childhood morbidity and mortality worldwide, and account for about 30% of all childhood deaths in the developing world. On the other hand, ARTIs cause loss of time, labor and huge healthcare costs directly or indirectly, especially in developed countries (8) . Detection and classification of the common respiratory pathogens are impressively important because of the fact that pathogens have potentially high morbidity and mortality rates. Culture-based, antigen-based (FA or direct antigen detection), and molecular techniques are currently used as diagnostic methods. Among them, molecular methods have the potential for the highest sensitivity, with assay turn-around times on the order of a few hours and foreseeable capability to be run in a high-throughput batch process (3). Several multiplex techniques have been developed so far which have the capacity to identify the majority of common respiratory viruses and bacteria in clinical samples (9) . The ResPlex I and II assays provide a rapid and easy test for semi-quantitation of viral and bacterial material present in respiratory samples (1, 9) . Both assays can be performed daily with acceptable sensitivities and specificities. Another advantage of simultaneous detection of a panel of pathogens is the recognition of co-infection. When monoplex RT-PCR is used for pathogen detection, the clinician often does not consider the possible presence of other possible pathogens (5) . However, the ResPlex I/II assays do not detect any DNA from the other bacteria and viruses associated with the respiratory tract infections, not including in the kits, suggesting a high analytical specificity (1) .
Besides this, the ResPlex II assay panel does not include several important viral pathogens, including bocavirus and members of the coronavirus family (such as strains OC43, 229E, and NL63), which are reported to occur at frequencies of approximately 12% and 5 to 10%, respectively (10) (11) (12) (13) . We detected in the study that ResPlex I and II systems identified 221 respiratory pathogens, including 91 bacterial and 130 viral. The most common bacterial and viral pathogens were S. pneumoniae and Rhinovirus, respectively. We identified more than one agent in 59 patients with a clinical suspicion of ARTI. The most frequent combination was co-infection with two different pathogens (45 of 59 patients). Although most of our study population was children, no pathogen was detected in 57% of the patients. M. pneumoniae, L. pneumophila, C. pneumoniae, and A. baumannii by the ResPlex I system and SARS-CoV, PIV-1, PIV-2, and PIV-4 by the ResPlex II system were not detected.
S. pneumoniae is one of the common pediatric pathogens causing invasive infection, such as ARTI and meningitides. H. influenzae is another common pediatric pathogen causing ARTI and meningitides (14) . Pneumococci have generally accounted for 25%-55% and H. influenzae has accounted for 3%-11% of the cases (15) . However, atypical organisms such as M. pneumoniae, C. pneumoniae or viruses were the most frequently isolated organisms. In some studies, various factors may explain these differences. Test methods used to detect respiratory pathogens were not applied equally or extensively in all studies (16) . In the study the most frequently detected bacterium was S. pneumoniae (24.4%). H. influenzae was found in 16.7%, being the second most common bacterial pathogen. Other bacterial agents including M. pneumoniae, L. pneumophila, C. pneumoniae, and A. baumannii were not detected. Various studies have found seasonal variations in ARTI with higher incidences for all age groups in the spring and winter (17, 18) . In the study, forty percent of bacteria were detected in spring, 26.3% in winter, 19.7% in autumn, and 13.1% in summer. This result was consistent with previous studies reported.
Respiratory viral infection is predisposed to bacterial secondary infections promoting bacterial adhesion to the respiratory epithelium (19) . Viral respiratory infections were also associated with a greater likelihood of isolation of H. influenzae and S. pneumoniae from sputum cultures, suggesting a link between viral infection and bacterial colonization (20) . Globally, respiratory viruses promote bacterial adhesion to respiratory epithelial cells. As adhesion is the first step toward colonization and infection, this viral "priming" has a significant impact on disease (21) . The significance of co-infection etiology has increasingly been appreciated in the literature, particularly in studies that apply new, sensitive diagnostic methods to identify infection with both bacteria and viruses (15) . Madhi and Klugman (22) and Peltola and McCullers (23) have reported that ~30% of respiratory viral infections predispose patients, both adults and children, to bacterial superinfection. Previous studies using the multiplex PCR system showed coinfections in numerous samples (9) . In the study, coinfections found multiple bacterial and viral pathogens or a combination of bacterial and viral pathogens. The two different pathogens is the most frequent combination. The prevalence of co-infection is ~40%, finding a much higher incidence of co-infection with more than one agent than that reported previously. The differences in the incidence of co-infection may reflect geographic differences or differences in etiologic agents or diagnostic methods.
